The White House said that President Donald Trump would consider signing legislation toughening sanctions on Russia after Senate and House leaders reached agreement on a bill for stronger action against Moscow.
Business & Financial News, U.S & International Breaking News
Republican strategy on healthcare bill in flux ahead of vote
Republican Senate leaders aim to hold a procedural vote as early as Tuesday to take up legislation to repeal or replace Obamacare, but it remained unclear which version of the bill senators would vote on.
U.S. venture capital's digital coin quandary: cash-rich startups
U.S. venture capital firms lining up for a slice of the burgeoning digital currency market are grappling with a novel challenge - some of the hottest tech startups that sell the coins just don't need their money.
IMF maintains global growth forecasts; China, eurozone revised higher
The International Monetary Fund kept its growth forecasts for the world economy unchanged for this year and next, although it revised up growth expectations for the eurozone and China.
EPA chief spent almost half of spring in home state of Oklahoma
The head of the U.S. Environmental Protection Agency, Scott Pruitt, was in his home state of Oklahoma on at least 43 of the 92 days of March, April and May, according to copies of his travel records obtained by the Environmental Integrity Project watchdog group and reviewed by Reuters.
Oil inches up ahead of producer meeting; Nigeria, Libya output in focus
Oil prices inched up but held near a one-week low on Monday ahead of a joint OPEC and non-OPEC meeting later in the day that may address rising output in Nigeria and Libya.
Japan PM Abe denies favors for friend amid falling support
Japanese Prime Minister Shinzo Abe, his ratings sinking over a suspected cronyism scandal, on Monday said he had never instructed officials to give preferential treatment to a long-time friend, adding that the latter had never sought favors.
Exp: Jul 17
Exp: Jul 17
Exp: Aug 17
Japan's Mitsubishi Tanabe Pharma Corp said on Monday it will acquire Israeli drug maker Neuroderm for $1.1 billion in an all-cash deal to expand its overseas business.